Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures
| Autor: | Michael Boyer, Jo Anna Reems, Pam Jacobson, Julie K. Morris, Jan Pierce, Linda L. Kelley, Mariluz P. Mojica-Henshaw |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Serum
Cancer Research Stromal cell medicine.medical_treatment Immunology Cell Culture Techniques Biology Flow cytometry Andrology medicine Immunology and Allergy Animals Humans Platelet Genetics (clinical) Cell Proliferation Transplantation medicine.diagnostic_test Platelet-Rich Plasma Growth factor Mesenchymal stem cell Mesenchymal Stem Cells Cell Biology equipment and supplies Flow Cytometry Culture Media Oncology Adipose Tissue Platelet-rich plasma Platelet lysate Cattle Fetal bovine serum |
| Zdroj: | Cytotherapy. 15(12) |
| ISSN: | 1477-2566 |
| Popis: | Background aims Fetal bovine serum (FBS) is commonly used as a serum supplement for culturing human mesenchymal stromal cells (hMSCs). However, human cells grown in FBS, especially for extended periods, risk potential exposure to bovine immunogenic proteins and infectious agents. To address this issue, we investigated the ability of a novel human platelet serum supplement to substitute for FBS in hMSC cultures. Methods Platelet lysate-serum (PL-serum) was converted from platelet lysate-plasma (PL-plasma) that was manufactured from pooled platelet-rich plasma (PRP) apheresis units. Growth factor levels and the number of residual intact platelets in PL-serum and PL-plasma were compared with enzyme-linked immunosorbent assays and flow cytometry, respectively. Proliferation responses of hMSCs cultured in PL-serum, PL-plasma, or FBS were assessed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, the immunophenotype of harvested hMSCs was evaluated by flow cytometry and tri-lineage differentiation potential was evaluated by assessing adipogenic, osteogenic and chondrogenic development. Results Selected growth factor levels in PL-serum were not significantly different from PL-plasma ( P > 0.05). hMSC cultures supplemented with PL-serum had comparable growth kinetics to PL-plasma, and hMSC yields were consistently greater than with FBS. hMSCs harvested from cultures supplemented with PL-serum, PL-plasma or FBS had similar cell surface phenotypes and maintained tri-lineage differentiation potential. Conclusions PL-serum, similar to PL-plasma, can substitute for FBS in hMSC cultures. Use of PL-serum, in contrast to PL-plasma, has an added advantage of not requiring addition of a xenogeneic source of heparin, providing a completely xeno-free culture medium. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect